Reporting rates of rhabdomyolysis with statins to the FDA Incidence study 09 February 2013 Pages: 20 - 20
OC use for 3 or more years increases the risk of focal nodular hepatic hyperplasia Incidence study 09 February 2013 Pages: 21 - 21
Risedronic acid is not associated with increased GI events Clinical study 09 February 2013 Pages: 21 - 21
Unexpected toxicity with combined interferon-α-2a and thalidomide Clinical study 09 February 2013 Pages: 21 - 21